LA JOLLA, Calif., Sept. 18, 2018 /PRNewswire/ -- Wamberg Genomic Advisors and National Benefit Partners (NBP) have partnered to distribute Wamberg's Cancer Guardiantm program as an employee benefit to leading employers nationwide. Cancer Guardian is a leading advancement in personalizing cancer support and treatment. Wamberg Genomic Advisors is the first company dedicated to making genomic programs readily available at prices everyone can afford. National Benefit Partners (NBP) is an independent marketing organization specializing in voluntary benefits and delivering turnkey product and service platforms.
This program offering through NBP is the first of its kind, as it provides participants access to three key features: 1) comprehensive cancer genomic profiling, 2) a dedicated cancer support specialist and, 3) digital medical records management.
Comprehensive cancer genomic profiling identifies genetic mutations found in a patient's tumor or blood sample. The information from this advanced DNA testing can be used to improve the accuracy of the initial diagnosis, and to help the treating physician choose the treatment options that have the greatest chance of success.
The Dedicated Cancer Support Specialists are compassionate, oncology trained nurses assigned to each patient. These nurses will always be familiar with the landscape and path to managing and living with cancer. The Cancer Support Specialist is the center point of expert guidance during a critical life event. Additionally, a second opinion pathology review is included in the Cancer Guardian offering, as well as an Onsite Nurse Navigator that can attend an appointment with the patient and their physician.
Medical Records Management: The Cancer Guardian Medical Records Storage & Transmission Platform is a secure, HIPAA compliant, user friendly, cloud-based solution for storing and accessing medical records, including radiological images. This platform gives patients the freedom to connect with doctors, clinics, family members, insurance providers and their Cancer Support Specialists in a convenient and efficient way. Cancer Guardian enrollees can use this service at any time, for any condition.
A 2017 Wamberg survey revealed that 65 percent of respondents said they would be interested if their employer offered easy access to genetic testing for health purposes.
"A single comprehensive genomic profiling test for a cancer patient can cost an employee anywhere from $5,800 to $10,000 in out-of-pocket expenses, this benefit costs between $8 and $19 per employee per month. And, Cancer Guardian is a benefit where a company is truly making a personal commitment to each employee. Each cancer diagnosis is personal to the patient, and their treatment plans should be equally personal," said Tom Wamberg, president and CEO of Wamberg Genomic Advisors.
The monthly cost of Cancer Guardian depends on the age of the employee. When an employee has any cancer related question, or is diagnosed with cancer, they can simply contact the Cancer Guardian Line and the Cancer Support Specialist will help assist in providing the appropriate personalized support and program benefits.
According to Brian Jund, President of NBP West, "This is an innovative benefit that fits right into our 'best-in-class' portfolio of products and services. We see this complementing our Critical Illness and Cancer benefit offerings as well as appealing to employees who have a family history of cancer."
About National Benefit Partners
National Benefit Partners (NBP) is an independent marketing organization specializing in voluntary benefits and delivering turnkey product and service platforms to our Allied Distributors. Our mission is to provide comprehensive benefit solutions to employees and their families through our Allied Distributor partners across the country. Our national footprint provides leverage enabling our Allied Distributors to deliver the most competitive and affordable benefits that meet and exceed their customers' expectations. For more information go to www.NationalBenefitPartners.com
About Wamberg Genomic Advisors
Wamberg Genomic Advisors is the first company dedicated to making genomic based programs and services available at prices everyone can afford. Advanced DNA testing can provide insights to individuals and healthcare providers for better-informed decisions about overall health, patient care paths and the quality and longevity of life. Wamberg Genomic Advisors delivers genomic products and services to employers and their employees via their trusted benefit brokers, and to policyholders of life insurance companies through qualified agents. To discover more about Wamberg Genomic Advisors and the future of genomics, visit wamberggenomic.com and cancerguardian.com
SOURCE Wamberg Genomic Advisors
These press releases may also interest you